Invesco Ltd. United Therapeutics Corp Transaction History

Invesco Ltd.

$453 Billion
Q1 2024

A detailed history of Invesco Ltd. transactions in United Therapeutics Corp stock. As of the latest transaction made, Invesco Ltd. holds 442,672 shares of UTHR stock, worth $139 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

442,672

Previous 225,328 96.46%

Holding current value

$139 Million

Previous $49.5 Million 105.24%

% of portfolio

0.02%

Previous 0.01%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$210.76 - $249.51 $45.8 Million - $54.2 Million	217,344 Added 96.46%	442,672 $102 Million
Q4 2023 Feb 12, 2024	SELL	$214.88 - $256.94 $618,854 - $739,987	-2,880 Reduced 1.26%	225,328 $49.5 Million
Q3 2023 Nov 13, 2023	SELL	$211.82 - $248.24 $22.5 Million - $26.4 Million	-106,416 Reduced 31.8%	228,208 $51.5 Million
Q2 2023 Aug 11, 2023	SELL	$205.19 - $232.99 $3.14 Million - $3.56 Million	-15,293 Reduced 4.37%	334,624 $73.9 Million
Q1 2023 May 12, 2023	SELL	$212.99 - $276.17 $2.82 Million - $3.66 Million	-13,242 Reduced 3.65%	349,917 $78.4 Million

Q4 2022 Feb 13, 2023	BUY	$205.95 - $280.43 $16.1 Million - $22 Million	78,370 Added 27.52%	363,159 $101 Million
Q3 2022 Nov 14, 2022	BUY	$203.3 - $244.17 $2.64 Million - $3.17 Million	12,971 Added 4.77%	284,789 $59.6 Million
Q2 2022 Aug 15, 2022	BUY	$174.81 - $241.14 $6.87 Million - $9.47 Million	39,287 Added 16.9%	271,818 $64.1 Million
Q1 2022 May 16, 2022	SELL	$166.16 - $213.96 $8.65 Million - $11.1 Million	-52,086 Reduced 18.3%	232,531 $41.7 Million
Q4 2021 Feb 14, 2022	SELL	$184.32 - $216.08 $12.3 Million - $14.4 Million	-66,710 Reduced 18.99%	284,617 $61.5 Million
Q3 2021 Nov 15, 2021	SELL	$179.86 - $214.88 $39 Million - $46.6 Million	-216,808 Reduced 38.16%	351,327 $64.8 Million
Q2 2021 Aug 17, 2021	SELL	$170.47 - $211.93 $11 Million - $13.7 Million	-64,621 Reduced 10.21%	568,135 $102 Million
Q1 2021 May 17, 2021	BUY	$153.94 - $174.85 $6.52 Million - $7.4 Million	42,350 Added 7.17%	632,756 $106 Million
Q4 2020 Feb 16, 2021	SELL	$101.87 - $151.79 $10.7 Million - $16 Million	-105,097 Reduced 15.11%	590,406 $89.6 Million
Q3 2020 Nov 16, 2020	BUY	$99.9 - $121.13 $4.81 Million - $5.84 Million	48,174 Added 7.44%	695,503 $70.2 Million
Q2 2020 Aug 14, 2020	BUY	$92.74 - $125.82 $50.3 Million - $68.2 Million	541,893 Added 513.95%	647,329 $78.3 Million
Q1 2020 May 15, 2020	BUY	$79.39 - $115.35 $278,023 - $403,955	3,502 Added 3.44%	105,436 $10 Million
Q4 2019 Feb 14, 2020	SELL	$78.31 - $95.34 $12.5 Million - $15.2 Million	-159,271 Reduced 60.98%	101,934 $8.98 Million
Q3 2019 Nov 14, 2019	BUY	$74.85 - $85.99 $17.2 Million - $19.7 Million	229,325 Added 719.34%	261,205 $20.8 Million
Q2 2019 Aug 14, 2019	SELL	$76.06 - $120.81 $21.7 Million - $34.4 Million	-284,719 Reduced 89.93%	31,880 $2.49 Million
Q1 2019 May 15, 2019	SELL	$107.15 - $126.84 $1.39 Million - $1.64 Million	-12,930 Reduced 3.92%	316,599 $37.2 Million
Q4 2018 Feb 14, 2019	BUY	$101.4 - $128.73 $33.4 Million - $42.4 Million	329,529 New	329,529 $35.9 Million

Others Institutions Holding UTHR

# of Institutions

561

Shares Held

43.1M

Call Options Held

501K

Put Options Held

529K

View Full List

About UNITED THERAPEUTICS Corp

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $14.3B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

More about UTHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account